The smart way to learn. The smart way to teach.

MRCOG PART 2 SBAs and EMQs

Course PAID
notes329
EMQ1315
SBA1606
Do you realy want to delete this discussion?
Forum >>

Question ?

Question ? Posted by Katarzyna K.
A Tibolone B Switch to continuous combined HRT
C Testosterone gel D Testosterone implant
E Vaginal oestrogen cream    

 

Explanation
Question 16 A 49 year old woman is referred to the gynaecology clinic complaining of low libido which is now adversely affecting her marriage. She has been on sequential combined hormone replacement therapy for 3 years to manage menopausal symptoms.

Why is the correct answer implant rather than topical use?

BMS suggests use of gels; the implants are not easily available.

Posted by Katarzyna K.
Options for Questions 11-11
A Reassure and discharge B Explain that risks of HRT outweigh benefits
C Oral oestrogen + progestogen replacement D Oral oestrogen + progestogen replacement for up to 6 months
E Oral oestrogen + progestogen replacement for up to 12 months F Trans-dermal oestrogen + progestogen replacement
G Oral or trans-dermal oestrogen + progestogen replacement H SELECT SQL_CALC_FOUND_ROWS SQL_CALC_FOUND_ROWSive serotonin re-uptake inhibitors
I Oral oestrogens + levonorgestrel IUS J Oral oestrogen

 

Instructions: For each scenario described below, choose the single most appropriate management from the above list of options. Each option may be used once, more than once, or not at all.
Explanation
Question 11 A healthy 51 year old woman attends the gynaecology clinic because of severe hot flushes. Her last menstrual period was 3 months ago and she has been having irregular periods every 1-6 months for the last 2 years. She has no significant personal or family history

Could you please advice Why is the answer transdermal, rather than oral or transdermal? 

Thank you!

Contraception interactions Posted by Katarzyna K.
Options for Questions 10-10
A 30 mcg combined contraceptive pill (COCP) B COCP or progestogen-only pill
C COCP or progestogen implant D COCP, progestogen-only pill or progestogen implant
E COCP or depo-medroxyprogesterone acetate F Progestogen implant only
G Depo-medroxyprogesterone acetate only H Cu IUCD only
I Cu IUCD, progestogen-only pill or progestogen implant J COCP or Cu IUCD
K COCP, Cu IUCD or progestogen implant    

 

Instructions: For the scenario below, choose the single most appropriate management from the above list of options. Each option may be used once, more than once, or not at all.
Explanation
Question 10 A 23 year old woman with epilepsy has a spontaneous vaginal birth at 38 weeks gestation. She has a history of epilepsy treated with lamotrigine. She is not breast-feeding and wishes to discuss contraception. Which option(s) would you recommend?

Why is the correct answer I?

The FSRH guideline on interactions suggests that It is possible that contraceptive effectiveness of combined hormonal contraception, all progestogenonly pills and the etonogestrel implant could be reduced during use of lamotrigine. Should the answer not be H?

Posted by Farrukh G.

Q1 - this question is no longer on the database

Q2 - EXPLANATION PROVIDED - please read explanation:

Vaso-motor symptoms 

  • Vasomotor symptoms (VMS), hot flushes and night sweats are the hallmarks of menopause, occurring in approximately 75% of postmenopausal women, with 25% of these being severely affected.
  • The percentage of women reporting hot flushes varies across countries and ethnic backgrounds.
  • Symptoms may resolve in 2–5 years but the median duration is 7 years and sometimes longer.
  • Offer HRT to people with vasomotor symptoms associated with menopause 
  • Consider menopause-specific cognitive behavioural therapy (CBT) as an option for vasomotor symptoms associated with menopause:
  1. in addition to HRT or
  2. for people for whom HRT is contraindicated or
  3. for those who prefer not to take HRT 
  • Do not routinely offer SSRIs, SNRIs or clonidine as first-line treatment for vasomotor symptoms alone 
  • All options should be offered but transdermal HRT preferable because of better side-effect profile and lower VTE risk compared to oral HRT.